Microbot Medical Inc (MBOT)

$1.64 -0.14 (-7.87%)
Market Cap 36.03M
Revenue (ttm) 0.00
Net Income (ttm) -10.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,458,300
Avg Vol 2,788,628
Day's Range N/A - N/A
Shares Out 20.24M
Stochastic %K 30%
Beta 1.46
Analysts Strong Sell
Price Target $7.00

Latest News on MBOT

Microbot Medical Closes $8.6 Million Registered Direct Offering

Jan 10, 2025, 10:25 AM EST - 7 days ago

Microbot Medical Closes $8.6 Million Registered Direct Offering

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Jan 7, 2025, 4:15 PM EST - 10 days ago

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Dec 30, 2024, 8:30 AM EST - 18 days ago

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Dec 10, 2024, 10:18 AM EST - 5 weeks ago

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Oct 15, 2024, 8:38 AM EDT - 3 months ago

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Sep 30, 2024, 8:30 AM EDT - 3 months ago

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Sep 17, 2024, 8:30 AM EDT - 4 months ago

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

Aug 22, 2024, 8:30 AM EDT - 5 months ago

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

Aug 13, 2024, 8:30 AM EDT - 5 months ago

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

Aug 1, 2024, 8:30 AM EDT - 6 months ago

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

Jul 18, 2024, 8:30 AM EDT - 6 months ago

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

Jul 9, 2024, 8:30 AM EDT - 6 months ago

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

Jul 8, 2024, 8:20 AM EDT - 6 months ago

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

Jul 3, 2024, 8:20 AM EDT - 7 months ago

Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

Jun 20, 2024, 8:25 AM EDT - 7 months ago

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

Jun 17, 2024, 8:30 AM EDT - 7 months ago

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jun 4, 2024, 4:20 PM EDT - 8 months ago

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jun 3, 2024, 12:11 PM EDT - 8 months ago

Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial

Jun 3, 2024, 8:20 AM EDT - 8 months ago

Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial

Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™

Apr 29, 2024, 8:30 AM EDT - 9 months ago

Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™

Microbot Medical Shares Status Following Recent Geopolitical Events

Apr 15, 2024, 8:30 AM EDT - 9 months ago

Microbot Medical Shares Status Following Recent Geopolitical Events

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

Feb 5, 2024, 7:30 AM EST - 1 year ago

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters

Jan 30, 2024, 7:20 AM EST - 1 year ago

Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters

Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study

Jan 18, 2024, 7:20 AM EST - 1 year ago

Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

Dec 29, 2023, 8:00 AM EST - 1 year ago

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met

Dec 28, 2023, 7:30 AM EST - 1 year ago

Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met

Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic

Dec 14, 2023, 8:15 AM EST - 1 year ago

Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic

Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study

Dec 7, 2023, 8:00 AM EST - 1 year ago

Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study

Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities

Nov 21, 2023, 9:12 AM EST - 1 year ago

Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities

Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process

Nov 13, 2023, 8:30 AM EST - 1 year ago

Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process

Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office

Nov 8, 2023, 9:10 AM EST - 1 year ago

Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office

Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical Study

Oct 31, 2023, 8:25 AM EDT - 1 year ago

Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical Study

Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024

Oct 24, 2023, 8:19 AM EDT - 1 year ago

Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024

Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against Company

Oct 19, 2023, 8:20 AM EDT - 1 year ago

Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against Company

Microbot Medical Announces Successful Initial Outcomes from Its Pivotal Pre-Clinical Study with the LIBERTY® Robotic Surgical System

Oct 17, 2023, 9:28 AM EDT - 1 year ago

Microbot Medical Announces Successful Initial Outcomes from Its Pivotal Pre-Clinical Study with the LIBERTY® Robotic Surgical System

Microbot Medical Engages CRO to Support its Upcoming U.S. Pivotal Clinical Trial

Sep 27, 2023, 8:30 AM EDT - 1 year ago

Microbot Medical Engages CRO to Support its Upcoming U.S. Pivotal Clinical Trial

Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023

Sep 8, 2023, 10:02 AM EDT - 1 year ago

Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023

Microbot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical System

Aug 15, 2023, 8:30 AM EDT - 1 year ago

Microbot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical System

Microbot Medical Strengthens Its Position Among US Interventional Radiologists by Appointing Professor Francois H. Cornelis to Its Scientific Advisory Board

Aug 10, 2023, 8:30 AM EDT - 1 year ago

Microbot Medical Strengthens Its Position Among US Interventional Radiologists by Appointing Professor Francois H. Cornelis to Its Scientific Advisory Board

Microbot Medical Engaging with a Leading Notified Body to Advance CE Mark for Sales in Europe

Jul 25, 2023, 9:23 AM EDT - 1 year ago

Microbot Medical Engaging with a Leading Notified Body to Advance CE Mark for Sales in Europe

Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory Board

Jul 11, 2023, 8:30 AM EDT - 1 year ago

Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory Board

Microbot Medical Raises a Total of $7.6 Million in Gross Proceeds from Four Recent Registered Direct Offerings

Jun 28, 2023, 2:05 PM EDT - 1 year ago

Microbot Medical Raises a Total of $7.6 Million in Gross Proceeds from Four Recent Registered Direct Offerings

Microbot Medical Expand IP protection in Japan

Jun 22, 2023, 8:36 AM EDT - 1 year ago

Microbot Medical Expand IP protection in Japan

Microbot Medical Announces Multiple Peer Reviewed Abstracts Accepted by The Cardiovascular and Interventional Radiological Society of Europe

Jun 16, 2023, 8:30 AM EDT - 1 year ago

Microbot Medical Announces Multiple Peer Reviewed Abstracts Accepted by The Cardiovascular and Interventional Radiological Society of Europe

Microbot Medical Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jun 6, 2023, 12:33 PM EDT - 1 year ago

Microbot Medical Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jun 2, 2023, 12:36 PM EDT - 1 year ago

Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Receives a Non-Dilutive Grant from The Israel Innovation Authority Supporting the Development of the Manufacturing Process for its Endovascular Surgical Robotic System

Jun 2, 2023, 8:15 AM EDT - 1 year ago

Microbot Medical Receives a Non-Dilutive Grant from The Israel Innovation Authority Supporting the Development of the Manufacturing Process for its Endovascular Surgical Robotic System

LIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory Process

May 31, 2023, 8:30 AM EDT - 1 year ago

LIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory Process

Lahey Hospital & Medical Center Agrees to become One of the U.S. Sites for the LIBERTY® Robotic System's First Human Trial

May 25, 2023, 8:40 AM EDT - 1 year ago

Lahey Hospital & Medical Center Agrees to become One of the U.S. Sites for the LIBERTY® Robotic System's First Human Trial

Microbot Medical Announces Closing of $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

May 24, 2023, 1:05 PM EDT - 1 year ago

Microbot Medical Announces Closing of $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules